The Future is Allogeneic - Translating a CRISPR Platform into Gene-Edited Cell Therapies

Mar 9, 2021 10:00am ‐ Mar 9, 2021 10:25am

Therapeutics I: Ex Vivo Editing

Mar 9, 2021 10:00am ‐ Mar 9, 2021 1:00pm

Genome Editing of Blood Cells to Cure Disease

Mar 9, 2021 10:25am ‐ Mar 9, 2021 10:50am

T-Cell Gene Editing for Cancer Immunotherapy

Mar 9, 2021 10:50am ‐ Mar 9, 2021 11:15am

Coffee Break

Mar 9, 2021 11:15am ‐ Mar 9, 2021 11:35am

An Adenine Base Editing Strategy for the Treatment of Sickle Cell Disease by Elimination of the Pathogenic Globin Protein

Mar 9, 2021 11:35am ‐ Mar 9, 2021 12:00pm

[NOT AVAILABLE ON DEMAND] Short Talk: Knockout of NKG2A by CRISPR in Human NK Cells Enhance their Cytotoxic Activity Against Solid Tumors

Mar 9, 2021 12:00pm ‐ Mar 9, 2021 12:15pm

Short Talk: Fast and Efficient Generation of TRAC-integrated CAR T Cells without Viruses

Mar 9, 2021 12:15pm ‐ Mar 9, 2021 12:30pm

Short Talk: Optimizing Stem Cell Lines for in vitro-derived Beta Cell Therapeutics via Genome-wide CRISPR Knock-out Screening

Mar 9, 2021 12:30pm ‐ Mar 9, 2021 12:45pm

Short Talk: Expanding the Scope of Marker-Free Selection for CRISPR-Driven Genome Editing in Human Cells

Mar 9, 2021 12:45pm ‐ Mar 9, 2021 1:00pm